Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX)
AMRX Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
10.30%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
23.50%
AMRX Stock Analysis
AMRX
PE Ratio:
33.9
AMRX
PEG Ratio:
2
AMRX
Forward EPS Growth (12 month):
16.90%
AMRX
PS Ratio:
1.3
AMRX
PSG Ratio:
0.2
AMRX
Forward Revenue Growth (12 month):
7.40%
AMRX Articles
No data was found